A detailed history of Auxier Asset Management transactions in Amgen Inc stock. As of the latest transaction made, Auxier Asset Management holds 8,710 shares of AMGN stock, worth $2.57 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
8,710
Previous 8,715 0.06%
Holding current value
$2.57 Million
Previous $2.72 Million 3.05%
% of portfolio
0.42%
Previous 0.43%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $1,546 - $1,686
-5 Reduced 0.06%
8,710 $2.81 Million
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $78,825 - $95,793
-300 Reduced 3.33%
8,715 $2.72 Million
Q4 2023

Feb 22, 2024

SELL
$255.7 - $288.46 $95,887 - $108,172
-375 Reduced 3.99%
9,015 $2.6 Million
Q3 2023

Nov 21, 2023

SELL
$218.65 - $271.46 $3,935 - $4,886
-18 Reduced 0.19%
9,390 $2.52 Million
Q2 2023

Aug 17, 2023

BUY
$214.27 - $253.37 $64,281 - $76,011
300 Added 3.29%
9,408 $2.09 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $45,158 - $55,040
200 Added 2.25%
9,108 $2.2 Million
Q4 2021

Mar 01, 2022

BUY
$198.88 - $227.6 $40,571 - $46,430
204 Added 2.34%
8,908 $2 Million
Q3 2021

Nov 18, 2021

BUY
$212.27 - $248.7 $733,605 - $859,507
3,456 Added 65.85%
8,704 $1.85 Million
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $26,629 - $31,032
120 Added 2.34%
5,248 $1.31 Million
Q3 2020

Mar 05, 2021

SELL
$234.65 - $260.95 $7,039 - $7,828
-30 Reduced 0.58%
5,128 $1.3 Million
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $182,240 - $241,700
-1,000 Reduced 16.24%
5,158 $1.05 Million
Q4 2019

Feb 21, 2020

SELL
$189.21 - $243.2 $9,460 - $12,160
-50 Reduced 0.81%
6,158 $1.49 Million
Q3 2019

Nov 15, 2019

BUY
$174.11 - $208.62 $17,411 - $20,862
100 Added 1.64%
6,208 $1.2 Million
Q4 2018

Feb 13, 2019

SELL
$178.4 - $208.25 $3,568 - $4,165
-20 Reduced 0.33%
6,108 $1.19 Million
Q2 2018

Aug 15, 2018

BUY
$166.05 - $186.51 $177,673 - $199,565
1,070 Added 21.15%
6,128 $1.13 Million
Q1 2018

May 14, 2018

BUY
$169.43 - $198.0 $291,080 - $340,164
1,718 Added 51.44%
5,058 $862,000
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $6,751 - $7,543
40 Added 1.21%
3,340 $581,000
Q2 2017

Aug 16, 2017

BUY
N/A
3,300
3,300 $568,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Auxier Asset Management Portfolio

Follow Auxier Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Auxier Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Auxier Asset Management with notifications on news.